MedPath
HSA Approval

MABRON CAPSULE 50 mg

SIN08114P

MABRON CAPSULE 50 mg

MABRON CAPSULE 50 mg

April 5, 1995

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

N02AX02

tramadol

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD (Factory AZ)

Active Ingredients

TRAMADOL HCl

50 mg

Tramadol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MABRON CAPSULE 50 mg - HSA Approval | MedPath